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As further confi rmation of a fi rst human case of Rift 
Valley fever in 2007 in Comoros, we isolated Rift Valley 
fever virus in suspected human cases. These viruses are 
genetically closely linked to the 2006–2007 isolates from 
Kenya.
Identifi ed during the 1930s in Kenya, Rift Valley fever (RVF) is a zoonotic disease that circulates in many 
African countries and in the Arabian Peninsula (1,2). 
RVF virus (RVFV) epizootics are characterized by large 
sweeping abortion storms and substantial death rates in 
adult livestock (primarily sheep, goats, and cattle), with 
the death rate for newborn animals approaching 100% 
(3). Humans typically are infected by bites of infected 
mosquitoes or by percutaneous or aerosol exposure to 
contaminated fl uids from infected animals. In most human 
cases, RVF is characterized by a self-limiting febrile illness 
(2–5 days), which progresses to more serious complications 
(hepatitis, encephalitis, blindness, or hemorrhagic 
syndrome) in only 1%–2% of infected persons (4,5). A 
large epizootic–epidemic occurred during 2006–2007 on 
the eastern African mainland, predominantly in Kenya (6) 
and Madagascar, during 2 successive rainy seasons (7).
In July 2007, a 12-year-old boy with a 2-month 
history of severe encephalitis was transferred from the 
Grande Comore, Union of the Comoros, to Mayotte (8,9). 
RVF infection was confi rmed by IgM serologic analysis. 
Because of the proximity of Comoros and Mayotte, the 
RVF situation among humans in Mayotte was assessed. In 
serum samples from 7 humans with dengue-like syndromes, 
RVFV IgM or RVFV RNA was detected. We report the 
isolations and full sequence analysis of 2 RVF viral isolates 
from these serum specimens.
The Study
During January–April 2007, seven patients native to 
Mayotte were admitted to the hospital for severe dengue-
like syndromes. Two patients were RVF seropositive by 
IgM and IgG, and the other 5 were positive by RVFV-
specifi c reverse transcription PCR (RT-PCR) as detailed in 
Sissoko et al. (9). As described for other viruses, we used 
in-house IgM-capture enzyme immunoassays and in-house 
direct detection for IgG by using microplates coated with 
RVFV antigen and specifi c binding by using a peroxidase-
labeled goat anti-human IgG conjugate (10).
RVFV isolates were obtained on Vero E6 cells from 
the serum of 2 hospitalized patients (serum collected on 
February 21 and March 20, 2008). RNA extracted by using 
the RNaid Kit (Qbiogene, Carlsbad, CA, USA) was reverse 
transcribed by PCR and amplifi ed by using SuperScript 
One-Step RT-PCR with platinum Taq kit (Invitrogen, San 
Diego, CA, USA) with primers targeting the small, medium, 
and large segments (adapted from [11]). Overlapping RT-
PCR fragments were purifi ed by ultrafi ltration. Sequencing 
reactions were performed by using the Big Dye Terminator 
v1.1 cycle sequencing kit (Applied Biosystems, Foster 
City, CA, USA). Sequence chromatograms from both 
strands were obtained on automated sequence analyzer 
ABI3730XL (Applied Biosystems). For sequence analysis, 
contig assemblies and sequence alignments were performed 
by using BioNumerics version 6.6 (Applied-Maths, Sint-
Martens-Latem, Belgium).
We used 2 methods for phylogenetic reconstruction: 
maximum likelihood and the Bayesian inference. The 
best models of nucleotide substitution for each dataset 
were selected from the uncorrected and corrected Akaike 
Information Criterion, the Hannan and Quinn performance-
based decision theory and Bayesian Information Criterion 
of Jmodeltest version 0.1 and TREEFINDER version 
October 2008 (Munich, Germany, distributed by its 
author at www.treefi nder.de). The consensus substitution 
models proposed by the different software packages were 
selected for further analyses. Comparison of the maximum-
likelihood method implemented by the TREEFINDER 
program with others was performed on the small, medium, 
and large segments by using the neighbor-joining and 
maximum parsimony methods from Mega5 software and 
the Bayesian approach by using MrBayes version 3.0B4 for 
phylogenetic reconstruction with random starting trees and 
run for 2,000,000 generations, sampling the Markov chains 
at intervals of 100 generations (12,13). Branch support 
values were obtained by using nonparametric bootstrapping 
with 1,000 resampling for PhyML and TREEFINDER 
and the posterior probabilities for the Bayesian approach 
estimated on 10,000 samples (sample frequency set 
to every 100th generation by using the Markov Chain 
Monte Carlo sampling). We compared topologies of the 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 6, June 2012 969
Author affi liations: Centre de Coopération Internationale en 
Recherche Agronomique pour le Développement, Montpellier, 
France (C. Cêtre-Sossah, E. Albina); Institut Pasteur, Paris, France 
(H. Zeller, M. Grandadam, V. Caro, M. Bouloy); Centre Hospitalier 
de Mayotte, Mayotte (F. Pettinelli); and Centre de Coopération 
Internationale en Recherche Agronomique pour le Développement, 
Sainte-Clotilde, France (E. Cardinale)
DOI: http://dx.doi.org/10.3201/eid1806.110994
maximum-likelihood and Bayesian trees obtained for the 
different segments.
The complete genome sequences performed on 
2 human RVFV isolates from Mayotte referenced as 
2008/00099 and 2008/00101 (deposited in GenBank/
EMBL under accession nos. HE687302–HE687307) 
are embedded within the larger 2006–2007 East African 
clade, specifi cally within the lineage previously termed 
Kenya-1 (online Appendix Table, wwwnc.cdc.gov/
EID/article/18/6/11-0994-TA1.htm). The Kenya-1 virus 
lineage includes 18 isolates, 8 human isolates (035/
07Baringo Kenya 2007, SPU10315 Kenya 2007, Garissa 
004/006 Kenya 2006, Dod002/007Tanzania 2007, 
3162 Madagascar 2008, 3163 Madagascar 2008, 3164 
Madagascar 2008, 3165 Madagascar 2008), 2 mosquito 
isolates (KLFMsq091/07 Kenya 2007, 131B04/06Garissa 
Kenya 2006), and 8 livestock isolates (1602Mombassa 
Kenya 2007, 2820Garissa Kenya 2007, 3644Baringo 
Kenya 2007, 473Kajaido Kenya 2007, 0611Kenya 2007, 
3168 Madagascar 2008, 3169 Madagascar 2008, 3170 
Madagascar 2008). The Kenya 2 virus lineage comprises 
3 human isolates (1811Garissa Kenya 2006, 0094 Kenya 
2007, Tan001/007 Tanzania 2007).
Because maximum-likelihood and Bayesian tree 
topologies obtained for the 3 segments were similar, only 
the small segment is presented. The Figure shows the 
Bayesian tree topology based on all RVFV small segments, 
with the HB29 phlebovirus from the People’s Republic of 
China as an outgroup. Tree topologies are consistent with 
those generated in previous work (7,11). The reliability 
of the phylogenetic trees was confi rmed by performing 
bootstrap analysis. The Kenya 1 and Kenya 2 lineages 
clustered together with an overall bootstrap value of 92% 
but with sublineage bootstrap values of 56%–100%.
Conclusions
The work of Sissoko et al. (9) suggested the 
indigenous transmission of RVFV in humans in Mayotte. 
The geographic distribution of the 10 human serum 
samples found positive for RVFV in 2007 and 2008 was 
not spatially delimited. All case-patients were native to the 
island and resided in the following districts: Mamoudzou 
(3), Brandaboua (2), Dembeni (1), Sada (1), Chirongui (2), 
and Boueni (1). None reported travel into countries where 
RVF is endemic (9). The genomic analysis of the Mayotte 
isolates placed them within the 2006–2007 eastern African 
Kenya-1 lineage. RVF activity in Mayotte appears to be 
an expansion of the eastern African mainland 2007–2008 
outbreak. It illustrates the risk for introduction in Mayotte 
or other Comorian islands of infectious agents involved in 
outbreaks in neighboring eastern African coastal countries, 
the major source being livestock importation from the 
African mainland or Madagascar.
The recent data published on RVFV Malagasy strains 
(7,14) support an epidemic cycle with introduction of the 
virus from outbreaks on mainland eastern Africa rather than 
an enzootic cycle in Madagascar. RVFV has been isolated 
from at least 40 species of mosquitoes in 8 genera. Recent 
experimental RVFV infections on African mosquito species 
revealed that 8 species—Aedes palpalis (Newstead), Ae. 
mcintoshi Huang, Ae. circumluteolus (Theobald), Ae. 
calceatus Edwards, Ae. aegypti (L), Culex antennatus 
(Becker), Cx. pipiens (L), and Cx. quinquefasciatus Say—
are susceptible to infection, and that all except Ae. calceatus, 
Ae. aegypti, and Cx. quinquefasciatus transmitted RVFV 
by bite after oral exposure (15). In Mayotte, a preliminary 
study has shown that 4 species—Ae. circumluteolus, Cx. 
antennatus, Cx. quinquefasciatus, and Ae. aegypti—are 
present (T. Balenghien, V. Robert, pers. comm.).
Even if mosquito transmission might have occurred 
among some of the 7 reported RVF case-patients, contact 
with imported ruminants is the predominant means of 
exposure among these reported case-patients. However, 
further entomologic studies need to be conducted to 
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Figure. Fifty-two complete sequences of Rift Valley fever virus small 
genome segments aligned and analyzed by  the Bayesian program 
(MrBayes). Scale bar indicates nucleotide substitutions per site.
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identify all potential vector species in the island and animal 
surveys need to be conducted to help detect RVF at early 
stages to gain a better understanding of the ecologic and 
climatic factors that favor RVFV dissemination. These 
assessments will help in the development of appropriate 
control measures to better predict and respond to potential 
RVF outbreaks.
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Appendix Table. Strains analyzed in study of Rift Valley fever virus, Mayotte 
Source of isolate Virus strain Country of origin Year isolated 
GenBank accession no. 
for small segment 
Bovine 763/70 Zimbabwe 1970 DQ380174 
Bovine 1260/78 Zimbabwe 1978 DQ380164 
Bovine 1853/78 Zimbabwe 1978 DQ380168 
Bovine 2250/74 Zimbabwe 1974 DQ380143 
Bovine 2269/74 Zimbabwe 1974 DQ380173 
Bovine 2373/74 Zimbabwe 1974 DQ380159 
Human 73HB1230 Central African Republic 1973 DQ380172 
Human 73HB1449 Central African Republic 1973 DQ380162 
Human 74HB59 Central African Republic 1974 DQ380163 
Aedes cuminsi mosquito ArD38388 Burkina Faso 1983 DQ380181 
Hipposideros caffer bat ANK3837 Guinea 1981 DQ380165 
Micropterus pusillus bat ANK6087 Guinea 1984 DQ380166 
Human CARR1622 Central African Republic 1985 DQ380160 
Eretmapodites sp. mosquito Entebbe Uganda 1944 DQ380156 
Human HvB375 Central African Republic 1985 DQ380161 
Bovine KenyaIB8 Kenya 1965 DQ380176 
Ae. macintoshi mosquito Kenya21445 Kenya 1983 DQ380171 
Human Kenya00523 Kenya 1998 DQ380169 
Human MgH824 Madagascar 1979 DQ380144 
Human OS1 Mauritania 1987 DQ380180 
Human OS3 Mauritania 1987 DQ380178 
Human OS8 Mauritania 1987 DQ380177 
Human OS9 Mauritania 1987 DQ380179 
Ovine SA51 South Africa 1951 DQ380158 
Human SA75 South Africa 1975 DQ380175 
Human Saudi10911 Saudi Arabia 2000 DQ380170 
Bovine ZC3349 Egypt 1978 DQ380152 
Human ZH501 Egypt 1977 DQ380149 
Human ZH548 Egypt 1977 DQ380151 
Human ZH1776 Egypt 1978 DQ380153 
Mosquito ZM657 Egypt 1978 DQ380146 
Ovine ZS6365 Egypt 1979 DQ380145 
Human Zinga Central African Republic 1969 DQ380167 
Bovine 0611MeruSouth Kenya 2007 EU574078 
Bovine 0094Garissa Kenya 2007 EU574086 
Buffalo 2820Garissa Kenya 2007 EU574061 
Human 2008/00099 Mayotte 2008 HE687302 
Human 2008/00101 Mayotte 2008 HE687307 
Bovine An1000 Madagascar 1991 EU312108 
Human 3162 Madagascar 2008 JF311386 
Human 3163 Madagascar 2008 JF311387 
Human 3164 Madagascar 2008 JF311388 
Human 3165 Madagascar 2008 JF311389 
Bovine 3168 Madagascar 2008 JF311392 
Bovine 3169 Madagascar 2008 JF311393 
Bovine 3170 Madagascar 2008 JF311394 
Human SPU10315 Kenya 2007 EU312147 
Human SPU384001 Kenya 1997 EU312128 
Human B1143 Kenya 1977 EU312119 
Goat 1811Garissa Kenya 2006 EU574068 
Bovine 1602Mombassa Kenya 2007 EU574071 
Ovine 473Kajaido Kenya 2007 EU574080 
Ovine 3644Baringo Kenya 2007 EU574059 
Human 004/006Garissa Kenya 2006 HM586975 
Human 035/07Barissa Kenya 2007 HM586980 
Aedes sp. mosquito 131B04/06Garissa Kenya 2006 HM586983 
Aedes sp. mosquito KLF091/07 Kenya 2007 HM586984 
Human Tanga001/007 Tanzania 2007 HM586981 
Human Dodoma002/07 Tanzania 2007 HM586982 
Human HB29 Phlebovirus China 2010 HM745932 
 
